Dr. Molokie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Chicago, IL 60612Phone+1 866-600-2273Fax+1 312-569-8114
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1983 - 1984
University of Illinois College of MedicineClass of 1983
Certifications & Licensure
IL State Medical License 1985 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease Start of enrollment: 2012 Aug 01
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
- A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease Start of enrollment: 2020 Jan 24
Publications & Presentations
PubMed
- Association of COMT rs4680 Genotype With Chronic Neuropathic Pain Experience in Patients With Sickle Cell Disease.Abigail R Islam, Gebre-Egziabher Kiros, Rachael O Ajiboye, Keesha Powell-Roach, Miriam O Ezenwa
Pain Management Nursing. 2024-12-28 - 1 citationsBarriers and Facilitators to Integrating Acupuncture into the U.S. Health Care System: A Scoping Review.Hongjin Li, Juanita E Darby, Ivy Akpotu, Judith M Schlaeger, Crystal L Patil
Journal of Integrative and Complementary Medicine. 2024-12-01 - Sex-stratified association of variants in the serotonin 1A receptor gene with acute crisis pain among African American patients with sickle cell disease.Nilanjana Sadhu, Ying He, Yavnika Kashyap, Giokdjen Ilktach, Michael A Wang
Experimental Hematology. 2024-11-28
Abstracts/Posters
- Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell DiseaseRobert E. Molokie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell DiseaseRobert E. Molokie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
$7.1M Grant to Review Opioid Alternatives to Treating Sickle Cell Disease PainOctober 5th, 2020
Genetic Variant Might Be a Better Marker for Heart DiseaseApril 11th, 2018
NIH Awards $4.6 Million for Chronic Pain ResearchFebruary 26th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
